Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Farrell

Showing results (1-10 of 522) with videos related to

Pageof 53
Sort By:
Child and Adolescent Mental Health|August 20, 2020
Young People and Substance MisuseMichael Farrell
Addiction (Abingdon, England)|July 21, 2010
Classification and confusionMichael Farrell
The International Journal on Drug Policy|September 9, 2022
From harm to hope or is it from harmful to hopeless?Michael Farrell
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2013
Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: commentaryMichael Farrell
Evidence-Based Mental Health|October 28, 2008
Review: Substance use disorders respond to psychosocial interventionsMichael Farrell
The Lancet. Psychiatry|February 14, 2016
Swift and certain approaches to reduce alcohol reoffendingMichael Farrell
BMJ (Clinical Research Ed.)|August 23, 2014
Drug legalisationMichael Farrell
Free Neuropathology|February 25, 2026
Reflections on a long career in NeuropathologyMichael Farrell
Addiction (Abingdon, England)|October 7, 2020
When the evidence is not enough: is it time to rethink trial design?Rebecca McKetin, Michael Farrell
Infection Control and Hospital Epidemiology|May 23, 2015
A new practical diagnostic test for Creutzfeldt-Jakob diseasePaul Brown, Michael Farrell
Pageof 53

Showing results (1-10 of 522) with videos related to

Sort By:
Pageof 53
Child and Adolescent Mental Health|August 20, 2020
Young People and Substance MisuseMichael Farrell
Addiction (Abingdon, England)|July 21, 2010
Classification and confusionMichael Farrell
The International Journal on Drug Policy|September 9, 2022
From harm to hope or is it from harmful to hopeless?Michael Farrell
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2013
Relapsing-remitting and primary progressive MS have the same cause(s)--the neuropathologist's view: commentaryMichael Farrell
Evidence-Based Mental Health|October 28, 2008
Review: Substance use disorders respond to psychosocial interventionsMichael Farrell
The Lancet. Psychiatry|February 14, 2016
Swift and certain approaches to reduce alcohol reoffendingMichael Farrell
BMJ (Clinical Research Ed.)|August 23, 2014
Drug legalisationMichael Farrell
Free Neuropathology|February 25, 2026
Reflections on a long career in NeuropathologyMichael Farrell
Addiction (Abingdon, England)|October 7, 2020
When the evidence is not enough: is it time to rethink trial design?Rebecca McKetin, Michael Farrell
Infection Control and Hospital Epidemiology|May 23, 2015
A new practical diagnostic test for Creutzfeldt-Jakob diseasePaul Brown, Michael Farrell
Pageof 53